(2024) Clearing the Path: Exploring Apoptotic Cell Clearance in Inflammatory and Autoimmune Disorders for Therapeutic Advancements. Molecular Biotechnology. ISSN 10736085 (ISSN)
Full text not available from this repository.
Abstract
Abstract: Inflammatory and autoimmune disorders, characterized by dysregulated immune responses leading to tissue damage and chronic inflammation, present significant health challenges. This review uniquely focuses on efferocytosis—the phagocyte-mediated clearance of apoptotic cells—and its pivotal role in these disorders. We delve into the intricate mechanisms of efferocytosis’ four stages and their implications in disease pathogenesis, distinguishing our study from previous literature. Our findings highlight impaired efferocytosis in conditions like atherosclerosis and asthma, proposing its targeting as a novel therapeutic strategy. We discuss the therapeutic potential of efferocytosis in modulating immune responses and resolving inflammation, offering a new perspective in treating inflammatory disorders. Graphical Abstract: (Figure presented.). © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.
| Item Type: | Article |
|---|---|
| Keywords: | Anti-inflammatory cytokines Apoptotic cell clearance Chronic inflammatory disease Phagocytes Resolution of inflammation Targeted therapy cytokine adverse drug reaction apoptosis asthma atherosclerosis autoimmune disease chronic inflammation clinical article commercial phenomena drug therapy efferocytosis human immune response inflammation inflammatory disease nonhuman pathogenesis phagocyte review therapy tissue injury |
| Journal or Publication Title: | Molecular Biotechnology |
| Journal Index: | Scopus |
| Identification Number: | https://doi.org/10.1007/s12033-024-01222-6 |
| ISSN: | 10736085 (ISSN) |
| Depositing User: | ms soheila Bazm |
| URI: | http://eprints.ssu.ac.ir/id/eprint/34251 |
Actions (login required)
 |
View Item |